Back to search

Article

Self-perceived general health at start of TNFi therapy predicts therapeutic response in patients with rheumatoid arthritis: analysis from the ATTRA registry

2022-05-17

Abstract excerpt

<h4>Background: </h4> Patient-reported outcomes (PROs) have been shown to predict various disease outcomes. One of the most widely used PRO instruments is the Short Form (SF) 36 questionnaire which evaluates the patient's health status. Our goal was to evaluate the association between therapeutic response and patients' self-perceived general health status at TNFi initiation based on answers to two selected questio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b23d16ea-33f7-5720-9421-9582fe8f92b4
DOI
10.21203/rs.3.rs-1643221/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Self-perceived general health at start of TNFi therapy predicts therapeutic response in patients with rheumatoid arthritis: analysis from the ATTRA registryDOI 10.21203/rs.3.rs-1643221/v1
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?Semantic proximity
PRECISE-RA: Predicting Remission and StratifyingRisk in Rheumatoid Arthritis Patients Treated withbDMARDs—A Robust Machine Learning ApproachSemantic proximity
Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registrySemantic proximity
Differences and Similarities in Clinical and Functional Responses Among Patients Receiving Tofacitinib Monotherapy, Tofacitinib Plus Methotrexate, and Adalimumab Plus Methotrexate: A Post-hoc Analysis of Data From Oral StrategySemantic proximity
Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss Clinical Quality Management cohortSemantic proximity
Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn’s Disease Patients: From Bedside to Bioinformatics.Semantic proximity
Effectiveness and Safety of Intravenous Golimumab With and Without Concomitant Methotrexate in Patients With Rheumatoid Arthritis in the Prospective, Noninterventional AWARE StudySemantic proximity
Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment.Semantic proximity
The impact of TNF inhibitors on glucocorticoid use among patients with inflammatory arthritides: A nationwide cohort studySemantic proximity
Systematic Review and Meta-analysis:Real-world Data Rates of Deep Remission With Anti-TNFα in Inflammatory Bowel DiseaseSemantic proximity
Factors Affecting Patient Satisfaction Related to Cost and Treatment Effectiveness in Rheumatoid Arthritis: Results From the Multicenter Observational Cohort Study, FRANK RegistrySemantic proximity
PREDIRA (PRediction mEdical DevIce for Rheumatoid Arthritis): Scale-up of unique predictive online platform highly improving the quality of life of Rheumatoid Arthritis’ patient by personalized and efficient biotherapies prescriptionSemantic proximity
Select a neighboring publication to make it the new centre.